San Antonio Regional Hospital, City of Hope partner to expand cancer care services

Upland, Calif.-based San Antonio Regional Hospital and Duarte, Calif.-based research, cancer and diabetes treatment center City of Hope signed an affiliation agreement to expand cancer care services to residents in the community.

Advertisement

Under the agreement, City of Hope will develop a multidisciplinary outpatient cancer care center at the hospital’s $160 million ambulatory center, which officials will begin construction on this year. City of Hope will also be responsible for naming the medical director of the oncology program and the medical director of the radiation oncology program for the cancer center.

The financial terms of the agreement were not disclosed.

“As a 109-year-old nonprofit hospital, our focus has always been to put patients’ needs first and foremost,” said Harris Koenig, president and CEO of San Antonio Regional Hospital. “Through this landmark affiliation, our patients will benefit greatly by being able to receive world class patient-centered cancer care close to their home and families. This is a significant positive milestone in the world of cancer care for the entire Inland Empire.”

More articles on transactions and valuations:
Christus Health acquires Good Shepherd Health System
Alecto Healthcare Services to acquire 2 Ohio hospitals
Genesis HealthCare, Kindred Healthcare form strategic clinical collaboration

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.